🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Five-Year Visual Function and Refractive Outcomes After Congenital Cataract Surgery

Recruitingn/aAges any - 18 YearsAllJin Yang
NCT07070037 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective multicenter observational study aims to evaluate the 5-year visual function and refractive outcomes in children undergoing surgery for congenital cataract. Key outcomes include best-corrected visual acuity, stereopsis, refractive error, and axial length growth. The study will help identify long-term trends and prognostic indicators after early cataract intervention in pediatric patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of congenital cataract * Underwent cataract extraction before 1 year of age * Available for regular follow-up for at least 5 years postoperatively * Written informed consent from legal guardian Exclusion Criteria: * Acquired cataract or traumatic origin * Associated ocular malformations (e.g., microphthalmia, coloboma) * Systemic syndromes affecting vision (e.g., Down syndrome) * History of secondary surgery affecting visual outcome
💊

What it tests

  • Not listed
📍

Where

1 site
Eye and ENT hospital of Fudan University
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy